Mary Eapen, MRCPI, MS, MBBS

Professor

view physician profile

Locations

Froedtert Hospital
Cancer Center - Froedtert Hospital

Specialties

Hematology
Medical Oncology

Languages

English

Education

MRCPI - Gen Med Royal College of Phy of Ireland
MS -Master of Science
MBBS - Doctor of Medicine

Biography

Dr. Eapen received her MBBS from Ahmadu Bello University, Zaria, Nigeria, in 1987. She completed a pediatric residency in 1997. In 2000, Dr. Eapen completed a fellowship in hematology/oncology/blood and bone marrow transplant and a MS in Clinical Research at the University of Minnesota, Minneapolis, Minnesota.

Research Interests

Mary Eapen, MD, MS, is Professor at the Medical College of Wisconsin and Senior Scientific Director - Research, Center for International Blood and Marrow Transplant Research. Her research focuses on the use of graft sources other than bone marrow for allogeneic hematopoietic cell transplantation for acute leukemia and marrow failure disorders.

Engraftment of Double Cord Blood Transplantation after Nonmyeloablative Conditioning with Escalated Total Body Irradiation Dosing to Facilitate Engraftment in Immunocompetent Patients.

(Brunstein CG, DeFor TE, Fuchs EJ, Karanes C, McGuirk JP, Rezvani AR, Eapen M, O'Donnell PV, Weisdorf DJ, Blood and Marrow Transplant Clinical Trials Network.) Transplant Cell Ther. 2021 Oct;27(10):879.e1-879.e3 PMID: 34273598 07/18/2021
Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders.

(Marsh RA, Hebert K, Kim S, Dvorak CC, Aquino VM, Baker KS, Chellapandian D, Dávila Saldaña B, Duncan CN, Eckrich MJ, Georges GE, Olson TS, Pulsipher MA, Shenoy S, Stenger E, Lugt MV, Yu LC, Gennery AR, Eapen M.) J Allergy Clin Immunol. 2021 Aug 08 PMID: 34375618 SCOPUS ID: 2-s2.0-85114615522 08/11/2021
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.

(Gooptu M, Romee R, St Martin A, Arora M, Al Malki M, Antin JH, Bredeson CN, Brunstein CG, Chhabra S, Fuchs EJ, Ghosh N, Grunwald MR, Kanakry CG, Kekre N, McGuirk JP, McNiece IK, Mehta RS, Mielcarek M, Milano F, Modi D, Reshef R, Solomon SR, Schroeder MA, Waller EK, Inamoto Y, Soiffer RJ, Eapen M.) Blood. 2021 07 22;138(3):273-282 PMID: 34292325 PMCID: PMC8310426 07/23/2021
Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR.

(Wieduwilt MJ, Stock W, Advani A, Luger S, Larson RA, Tallman M, Appelbaum F, Zhang MJ, Bo-Subait K, Wang HL, Bhatt VR, Dholaria B, Eapen M, Hamadani M, Jamy O, Prestidge T, Pulsipher M, Ritchie D, Rizzieri D, Sharma A, Barba P, Sandmaier BM, de Lima M, Kebriaei P, Litzow M, Saber W, Weisdorf D.) Leukemia. 2021 Jul;35(7):2140 PMID: 34088982 PMCID: PMC8329698 SCOPUS ID: 2-s2.0-85107597501 06/06/2021
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR.

(Wieduwilt MJ, Stock W, Advani A, Luger S, Larson RA, Tallman M, Appelbaum F, Zhang MJ, Bo-Subait K, Wang HL, Bhatt VR, Dholaria B, Eapen M, Hamadani M, Jamy O, Prestidge T, Pulsipher M, Ritchie D, Rizzieri D, Sharma A, Barba P, Sandmaier BM, de Lima M, Kebriaei P, Litzow M, Saber W, Weisdorf D.) Leukemia. 2021 07;35(7):2076-2085 PMID: 33785862 PMCID: PMC8257494 SCOPUS ID: 2-s2.0-85103388621 04/01/2021
HLA Haploidentical versus Matched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide based prophylaxis.

(Gooptu M, Romee R, St Martin A, Arora M, Al Malki MM, Antin JH, Bredeson CN, Brunstein CG, Chhabra S, Fuchs EJ, Ghosh N, Grunwald MR, Kanakry CG, Kekre N, McGuirk JP, McNiece I, Mehta RS, Mielcarek M, Milano F, Modi D, Reshef R, Solomon SR, Schroeder MA, Waller EK, Inamoto Y, Soiffer RJ, Eapen M.) Blood. 2021 Apr 13 PMID: 33851205 SCOPUS ID: 2-s2.0-85111698532 04/15/2021
Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors.

(Grunwald MR, Zhang MJ, Elmariah H, Johnson MH, St Martin A, Bashey A, Battiwalla M, Bredeson CN, Copelan E, Cutler CS, George BR, Gupta V, Kanakry C, Mehta RS, Milano F, Mussetti A, Nakamura R, Nishihori T, Saber W, Solh M, Weisdorf DJ, Eapen M.) Blood Adv. 2021 02 23;5(4):975-983 PMID: 33576783 PMCID: PMC7903230 SCOPUS ID: 2-s2.0-85102602689 02/13/2021
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation.

(Qayed M, Ahn KW, Kitko CL, Johnson MH, Shah NN, Dvorak C, Mellgren K, Friend BD, Verneris MR, Leung W, Toporski J, Levine J, Chewning J, Wayne A, Kapoor U, Triplett B, Schultz KR, Yanik GA, Eapen M.) Blood. 2021 02 18;137(7):983-993 PMID: 33206937 PMCID: PMC7918183 SCOPUS ID: 2-s2.0-85101021587 11/19/2020
Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial.

(Fuchs EJ, O'Donnell PV, Eapen M, Logan B, Antin JH, Dawson P, Devine S, Horowitz MM, Horwitz ME, Karanes C, Leifer E, Magenau JM, McGuirk JP, Morris LE, Rezvani AR, Jones RJ, Brunstein CG.) Blood. 2021 01 21;137(3):420-428 PMID: 33475736 PMCID: PMC7819761 SCOPUS ID: 2-s2.0-85092507677 01/22/2021
Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome.

(Wolska-Kusnierz B, Pastorczak A, Fendler W, Wakulinska A, Dembowska-Baginska B, Heropolitanska-Pliszka E, Piątosa B, Pietrucha B, Kałwak K, Ussowicz M, Pieczonka A, Drabko K, Lejman M, Koltan S, Gozdzik J, Styczynski J, Fedorova A, Miakova N, Deripapa E, Kostyuchenko L, Krenova Z, Hlavackova E, Gennery AR, Sykora KW, Ghosh S, Albert MH, Balashov D, Eapen M, Svec P, Seidel MG, Kilic SS, Tomaszewska A, Wiesik-Szewczyk E, Kreins A, Greil J, Buechner J, Lund B, Gregorek H, Chrzanowska K, Mlynarski W.) Clin Cancer Res. 2021 01 15;27(2):575-584 PMID: 33082212 SCOPUS ID: 2-s2.0-85100264437 10/22/2020
Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182] (Transplantation and Cellular Therapy (2020) 26/8(e177-e182) (S1083879120302251), (10.1016/j.bbmt.2020.04.013))

(D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM.) Transplantation and Cellular Therapy. 2021 SCOPUS ID: 2-s2.0-85108559179 01/01/2021
Double unrelated umbilical cord blood versus HLA-haploidentical bone marrow transplantation (BMT CTN 1101).

(Fuchs EJ, O'Donnell PV, Eapen M, Logan BR, Antin JH, Dawson P, Devine SM, Horowitz MM, Horwitz ME, Karanes C, Leifer E, Magenau JM, McGuirk JP, Morris LE, Rezvani AR, Jones RJ, Brunstein CG.) Blood. 2020 Aug 31 PMID: 32870242 SCOPUS ID: 2-s2.0-85092507677 09/02/2020